Biopharma Research Digitalization
Industry leaders discussed their experiences & experiments.
Digitalization is expanding across all areas in the Research domain, in this panel we will draw on the experiences of our diverse panellists covering some key use cases and learnings across Biopharma Research.
We will go beyond the basic LIMS/ELN tools into the real impact areas and challenges of making sense of this digital workflow, the digital asset, the decisions and supporting the huge volumes of data that are being generated now and in the future.
Influencing factors and strategies to consider for an ELN upgrade.
Imagine scrolling through social media and coming across an invitation to enroll in a clinical trial. Would you trust it?
Welcome to the new normal. For our pan-India virtual study on the global pandemic, we leveraged social media to help us reach the right subjects. Listen to how we built trust through social media for our decentralized trial.
Data Integrity Remediation
An analysis of warning letters and notices reveals that most R&D labs have insufficient measures to ensure Data Integrity compliance. In this video we discuss cost-effective ways to perform Data Integrity Remediation at your organization.
Answered: Impact of COVID-19 on Clinical Trials
Being part of the clinical research industry, we are confronted by the COVID-19 situation to demonstrate leadership and guide the world to safety. We need to ensure that research continues to happen even amidst this question of existence. Here we share our thoughts on the impact of COVID-19 on existing clinical trials.
ADaM IG: Grey areas addressed in a nutshell
CDISC released ADaM IG version in last quarter of 2019. Do you want to know what has been addressed but don't have the time to go through the document? No worries. Our CDISC Experts give insights to the new version of ADaM IG in this webinar.
The front office of CRF design to TLF generation
It's high time to configure library management system as a foreground service from CRF to TLF generation. Generally, we may work in a great number of simultaneously ongoing clinical trials, and most of the designs require the same set of standards. There are so many ways to configure an assortment based on requirements. But how do we ensure that the assortment is efficient and governed?
Master Protocol Risks and Opportunities
Did you know there are clinical trials that actually govern the studies of multiple drugs for the same indication or the same drug tested for multiple indications - all within ONE protocol? Welcome to the world of Master Protocols! In this video, our experts dive into the risks and opportunities associated with it, and discuss what to keep in mind while planning such studies.
Get in Touch
Office 7, 37-39 Shakespeare Street
T : +44 1223 969605
24, rue René Boulanger,
c/o Beil Staehle Milde,
T : +49 69 9451 5840
10 Anson Road,
27-15 International Plaza,
Humax Ebisu building,
7th floor, Ebisu Minami 1-1-1, Shibuya-Ku,
T : +81 3 4405 4140
Room 201, Building A, NOVASIOT
58 Xiangke Road, Zhangjiang
T : +86 21 5077 2711
St Alban-Anlage 46
7111 Syntex Drive,
Ontario L5N 8C3.